


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 31 Aug 2026
Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases
Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases
